(-)-demecolcine decreases expression ISO RGD:736174 6480464 Demecolcine results in decreased expression of CAMK2D mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736174 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CAMK2D mRNA CTD PMID:22079256 (S)-amphetamine affects expression ISO RGD:736175 6480464 Dextroamphetamine affects the expression of CAMK2D mRNA CTD PMID:12558987 1,1-dichloroethene increases expression ISO RGD:736175 6480464 vinylidene chloride results in increased expression of CAMK2D mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:736175 6480464 1, 2-Dimethylhydrazine results in decreased expression of CAMK2D mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:736175 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAMK2D mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CAMK2D mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:736174 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CAMK2D mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of CAMK2D mRNA CTD PMID:20660070 , PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CAMK2D mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:736175 6480464 2 more ... CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736175 6480464 Tetrachlorodibenzodioxin results in increased expression of CAMK2D mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CAMK2D mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAMK2D mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736175 6480464 Tetrachlorodibenzodioxin affects the expression of CAMK2D mRNA, Tetrachlorodibenzodioxin affects the expression of CAMK2D protein CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736175 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAMK2D mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:736174 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of CAMK2D protein CTD PMID:32044396 2-hydroxypropanoic acid decreases expression ISO RGD:736174 6480464 Lactic Acid results in decreased expression of CAMK2D mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases expression ISO RGD:736175 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CAMK2D mRNA CTD PMID:19285098 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736174 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAMK2D mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of CAMK2D mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CAMK2D mRNA CTD PMID:25380136 , PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:736174 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CAMK2D protein CTD PMID:34186270 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CAMK2D mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of CAMK2D mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CAMK2D mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:736174 6480464 Aflatoxin B1 results in decreased methylation of CAMK2D gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:736174 6480464 aflatoxin B2 results in increased methylation of CAMK2D intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:736174 6480464 Tretinoin results in increased expression of CAMK2D mRNA CTD PMID:23724009 , PMID:23830798 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CAMK2D mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:736174 6480464 aristolochic acid I results in decreased expression of CAMK2D mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:736174 6480464 [Arsenic co-treated with Iron] results in increased expression of CAMK2D mRNA CTD PMID:31739468 arsane increases expression ISO RGD:736174 6480464 Arsenic results in increased expression of CAMK2D mRNA CTD PMID:31739468 arsenic atom increases expression ISO RGD:736174 6480464 Arsenic results in increased expression of CAMK2D mRNA CTD PMID:31739468 arsenic atom multiple interactions ISO RGD:736174 6480464 [Arsenic co-treated with Iron] results in increased expression of CAMK2D mRNA CTD PMID:31739468 arsenous acid decreases expression ISO RGD:736175 6480464 Arsenic Trioxide results in decreased expression of CAMK2D mRNA CTD PMID:24831965 astemizole decreases expression EXP 6480464 Astemizole results in decreased expression of CAMK2D mRNA CTD PMID:20221588 benzatropine multiple interactions ISO RGD:736174 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of CAMK2D protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:736175 6480464 Benzo(a)pyrene results in decreased expression of CAMK2D mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:736174 6480464 Benzo(a)pyrene results in decreased expression of CAMK2D mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases expression ISO RGD:736175 6480464 Benzo(a)pyrene results in increased expression of CAMK2D mRNA CTD PMID:22228805 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CAMK2D mRNA CTD PMID:24066056 more ... bisphenol A decreases expression ISO RGD:736174 6480464 bisphenol A results in decreased expression of CAMK2D protein CTD PMID:34186270 bisphenol A increases methylation ISO RGD:736174 6480464 bisphenol A results in increased methylation of CAMK2D gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:736174 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CAMK2D gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAMK2D mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CAMK2D mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CAMK2D mRNA CTD PMID:26496021 Bisphenol B increases expression ISO RGD:736174 6480464 bisphenol B results in increased expression of CAMK2D protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:736174 6480464 bisphenol F results in increased expression of CAMK2D protein CTD PMID:34186270 butanal decreases expression ISO RGD:736174 6480464 butyraldehyde results in decreased expression of CAMK2D mRNA CTD PMID:26079696 cadmium atom multiple interactions EXP 6480464 KN 93 inhibits the reaction [Cadmium affects the localization of CAMK2D protein] CTD PMID:22553113 cadmium atom affects localization EXP 6480464 Cadmium affects the localization of CAMK2D protein CTD PMID:22553113 caffeine decreases phosphorylation ISO RGD:736174 6480464 Caffeine results in decreased phosphorylation of CAMK2D protein CTD PMID:35688186 calcium atom affects expression EXP 6480464 Calcium affects the expression of CAMK2D mRNA CTD PMID:15913539 calcium atom multiple interactions ISO RGD:736174 6480464 [Ionomycin co-treated with Calcium co-treated with CAMK2D protein] results in increased activity of TRPM4 protein CTD PMID:33392831 calcium(0) affects expression EXP 6480464 Calcium affects the expression of CAMK2D mRNA CTD PMID:15913539 calcium(0) multiple interactions ISO RGD:736174 6480464 [Ionomycin co-treated with Calcium co-treated with CAMK2D protein] results in increased activity of TRPM4 protein CTD PMID:33392831 carbamazepine affects expression ISO RGD:736174 6480464 Carbamazepine affects the expression of CAMK2D mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:736175 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:736174 6480464 CGP 52608 promotes the reaction [RORA protein binds to CAMK2D gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:736175 6480464 Chlorpyrifos results in increased expression of CAMK2D mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:736175 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CAMK2D mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CAMK2D mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:736174 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CAMK2D mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:736175 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of CAMK2D mRNA CTD PMID:23625948 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of CAMK2D mRNA CTD PMID:15860345 coumestrol multiple interactions ISO RGD:736174 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:736174 6480464 Coumestrol results in decreased expression of CAMK2D mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:736175 6480464 Asbestos, Crocidolite results in decreased expression of CAMK2D mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CAMK2D mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:736174 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of CAMK2D protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:736175 6480464 Cyclosporine results in decreased expression of CAMK2D mRNA CTD PMID:19770486 DDT increases methylation EXP 6480464 DDT results in increased methylation of CAMK2D gene CTD PMID:30207508 dexamethasone multiple interactions ISO RGD:736174 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAMK2D mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:736175 6480464 Arsenic Trioxide results in decreased expression of CAMK2D mRNA CTD PMID:24831965 diazinon affects expression EXP 6480464 Diazinon affects the expression of CAMK2D mRNA CTD PMID:22546817 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CAMK2D mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:736174 6480464 Doxorubicin results in decreased expression of CAMK2D mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CAMK2D mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:736174 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:736174 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CAMK2D protein CTD PMID:23301498 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CAMK2D mRNA CTD PMID:20655511 ethanol affects splicing ISO RGD:736175 6480464 Ethanol affects the splicing of CAMK2D mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:736174 6480464 Ethyl Methanesulfonate results in decreased expression of CAMK2D mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:736175 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 formaldehyde decreases expression ISO RGD:736174 6480464 Formaldehyde results in decreased expression of CAMK2D mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:736174 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CAMK2D gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of CAMK2D mRNA CTD PMID:27387713 genistein increases expression EXP 6480464 Genistein results in increased expression of CAMK2D mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CAMK2D mRNA CTD PMID:22061828 glyphosate increases expression ISO RGD:736174 6480464 glyphosate results in increased expression of CAMK2D mRNA CTD PMID:31295307 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of CAMK2D mRNA CTD PMID:15860345 indometacin multiple interactions ISO RGD:736174 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAMK2D mRNA CTD PMID:28628672 ionomycin multiple interactions ISO RGD:736174 6480464 [Ionomycin co-treated with Calcium co-treated with CAMK2D protein] results in increased activity of TRPM4 protein CTD PMID:33392831 iron atom multiple interactions ISO RGD:736174 6480464 [Arsenic co-treated with Iron] results in increased expression of CAMK2D mRNA CTD PMID:31739468 iron(0) multiple interactions ISO RGD:736174 6480464 [Arsenic co-treated with Iron] results in increased expression of CAMK2D mRNA CTD PMID:31739468 ivermectin decreases expression ISO RGD:736174 6480464 Ivermectin results in decreased expression of CAMK2D protein CTD PMID:32959892 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [Cadmium affects the localization of CAMK2D protein] CTD PMID:22553113 L-methionine multiple interactions ISO RGD:736175 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CAMK2D mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CAMK2D mRNA CTD PMID:22641619 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CAMK2D mRNA CTD PMID:33080273 lead(0) affects splicing ISO RGD:736174 6480464 Lead affects the splicing of CAMK2D mRNA CTD PMID:28903495 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CAMK2D mRNA CTD PMID:33080273 lead(0) affects expression ISO RGD:736174 6480464 Lead affects the expression of CAMK2D mRNA CTD PMID:28903495 mercury dibromide increases expression ISO RGD:736174 6480464 mercuric bromide results in increased expression of CAMK2D mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA CTD PMID:27188386 methotrexate increases expression ISO RGD:736174 6480464 Methotrexate results in increased expression of CAMK2D mRNA CTD PMID:21678067 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CAMK2D gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO RGD:736174 6480464 Methyl Methanesulfonate results in decreased expression of CAMK2D mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:736174 6480464 methylmercuric chloride results in increased expression of CAMK2D mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA CTD PMID:27188386 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CAMK2D mRNA CTD PMID:20360939 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CAMK2D mRNA CTD PMID:25380136 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CAMK2D mRNA CTD PMID:22546817 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CAMK2D mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:736174 6480464 p-Chloromercuribenzoic Acid results in increased expression of CAMK2D mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:736175 6480464 Acetaminophen affects the expression of CAMK2D mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CAMK2D mRNA CTD PMID:33387578 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CAMK2D mRNA CTD PMID:20360939 phenylephrine multiple interactions EXP 6480464 CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein] CTD PMID:15629441 phenylmercury acetate increases expression ISO RGD:736174 6480464 Phenylmercuric Acetate results in increased expression of CAMK2D mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CAMK2D mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:736175 6480464 pirinixic acid results in increased expression of CAMK2D mRNA CTD PMID:18301758 , PMID:18445702 potassium chloride multiple interactions EXP 6480464 CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] more ... CTD PMID:18004999 potassium chromate decreases expression ISO RGD:736174 6480464 potassium chromate(VI) results in decreased expression of CAMK2D mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:736174 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CAMK2D mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:736174 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CAMK2D mRNA CTD PMID:20660070 rac-lactic acid decreases expression ISO RGD:736174 6480464 Lactic Acid results in decreased expression of CAMK2D mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:736174 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CAMK2D mRNA CTD PMID:23557933 rotenone increases expression ISO RGD:736174 6480464 Rotenone results in increased expression of CAMK2D mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:736174 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:736174 6480464 Silicon Dioxide analog results in decreased expression of CAMK2D mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:736175 6480464 sodium arsenate results in increased expression of CAMK2D mRNA CTD PMID:21795629 succimer multiple interactions ISO RGD:736175 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAMK2D mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:736174 6480464 Sunitinib results in decreased expression of CAMK2D mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:736174 6480464 Testosterone results in decreased expression of CAMK2D mRNA CTD PMID:33359661 theophylline decreases expression ISO RGD:736174 6480464 Theophylline results in decreased expression of CAMK2D mRNA CTD PMID:18951874 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CAMK2D mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CAMK2D mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CAMK2D mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:736174 6480464 torcetrapib results in increased expression of CAMK2D mRNA CTD PMID:23228038 tributylstannane increases activity ISO RGD:736175 6480464 tributyltin results in increased activity of CAMK2D protein CTD PMID:20810541 triclosan decreases expression ISO RGD:736174 6480464 Triclosan results in decreased expression of CAMK2D mRNA CTD PMID:30510588 triptonide affects expression ISO RGD:736175 6480464 triptonide affects the expression of CAMK2D mRNA CTD PMID:33045310 uranium atom affects expression ISO RGD:736174 6480464 Uranium affects the expression of CAMK2D mRNA CTD PMID:15672453 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CAMK2D protein CTD PMID:17675408 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CAMK2D mRNA CTD PMID:19015723 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of CAMK2D gene CTD PMID:31079544 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CAMK2D mRNA CTD PMID:20566332 vincristine decreases expression ISO RGD:736174 6480464 Vincristine results in decreased expression of CAMK2D mRNA CTD PMID:23649840 zoledronic acid decreases expression ISO RGD:736174 6480464 zoledronic acid results in decreased expression of CAMK2D mRNA CTD PMID:24714768